Sponsor:
Aptose Biosciences Inc.
Code:
NCT03850574
Conditions
Leukemia, Myeloid, Acute
Refractory AML
Relapsed Adult AML
Myelodysplastic Syndrome with Excess Blasts-2
Chronic Myelomonocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tuspetinib
Venetoclax Oral Tablet
Azacitidine for Intravenous Infusion
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations